Vaginal access minimally invasive surgery system for removal of eroded sacrocolpopexy mesh

Rodriguez-Mias N1, Sabadell-Garcia J1, Montero-Armengol A1, Salicru-Riera S1, Gil-Moreno A1, Suarez-Salvador E1

Research Type

Clinical

Abstract Category

Pelvic Organ Prolapse

Abstract 863
Non Discussion Video
Scientific Non Discussion Video Session 200
Grafts: Synthetic Pelvic Organ Prolapse Surgery New Devices
1. Hospital Vall d'Hebron
Links

Abstract

Introduction
Natural orifice transluminal endoscopic surgery (NOTES) is a significant innovation in the field of minimally invasive surgery, and it has gained the most popularity, based on endoscopic instrumentation to perform routine and complex procedures vaginally. Hence, vNOTES is gaining remarkable interest in the field of gynecology for its safe utility in hysterectomy, adnexectomy, salpingectomy, vaginal vault suspension, myomectomy, and others.
Design
The objective of this video is to demonstrate a new use of the vNOTES device for a removal of an eroded sacrocolpopexy mesh.
This video demonstrates that vNOTES device can help the surgeons to perform routine and complex procedures vaginally demonstrating in this case, a new applicability with great results and clinical outcomes improvement.
Results
A 55-year-old patient was referred from Oncological Gynecology Unit to the Urogynecology Unit as during a exploratory laparoscopy under suspicion of vaginal cancer, it was discovered intraoperative a vaginal mesh erosion. 
The patient was unaware that 14 years ago she had undergone a vaginal hysterectomy, and ten years later, in the context of a dome prolapse, she had been under a laparoscopic sacrocolpopexy where a mesh and helical sutures at the level of the elevator muscle, vagina and sacral promontory were impanated. The patient’s history was uneventful without dyspareunia, incontinence, or voiding difficulties, and she was otherwise content with the sacrocolpopexy result. But, some months ago, she had begun with symptomatic increasingly foul-smelling vaginal discharge, and after a while she was referring vaginal bleeding.
Laparoscopic sacrocolpopexy shows superior outcomes for pelvic organ prolapse, with success rates of up to 96%, although an uncommon side effect might be a mesh erosion, occurring in up to 2.4%. In this video we show an alternative route for the excision of a symptomatic exposed mesh, as usually these are usually treated laparoscopically, in our case we performed a transvaginal approach based with the vNOTES.
The gel single-port platform was placed vaginally, and laparoscopic instruments were used as the mesh exposition was more than 10 cm away from the vaginal introitus and was Inaccessible through the classic vaginal route. The vNOTES device allowed us to see properly the exposed mesh to remove completely together with two helical anchorages that were also exposed. There were no signs of further infection of the residual mesh beyond the area exposed in the vagina. No complications occurred in the postoperative course and the follow-up visit  first and second month postoperatively the patient is asymptomatic, and the vaginal examination shows no recurrence neither other complications.
Conclusion
In summary, this video is aimed to provide urogynecology surgeons information on the new applicability of the vNOTES device in performing an excision of a symptomatic exposed vaginal mesh. Reinforcing the benefits of this new device to the patient, including shorter operative time, shorter length of stay, and lower pain scores.
References
  1. Li CB, Hua KQ. Transvaginal natural orifice transluminal endoscopic surgery (vNOTES) in gynecologic surgeries: A systematic review. Asian J Surg. 2020 Jan;43(1):44-51. doi: 10.1016/j.asjsur.2019.07.014. Epub 2019 Aug 20. PMID: 31444108.
  2. Baekelandt J, Cavens D. GelPOINT (applied medical) is a suitable port for Transvaginal NOTES procedures. J Gynecol Surg. 2016;32:257-262.
  3. SouthMM, Foster RT,Webster GD, et al. Surgical excision of erodedmesh after prior abdominal sacrocolpopexy. Am J Obstet Gynecol 2007;197:615. e1–615.e5.
Disclosures
Funding none Clinical Trial No Subjects None
17/07/2025 14:40:24